Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Net Cash Flow (2023 - 2025)

Fractyl Health (GUTS) has disclosed Net Cash Flow for 3 consecutive years, with $55.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow rose 406.06% year-over-year to $55.4 million, compared with a TTM value of -$7.0 million through Sep 2025, down 117.58%, and an annual FY2024 reading of $33.9 million, up 315.56% over the prior year.
  • Net Cash Flow was $55.4 million for Q3 2025 at Fractyl Health, up from -$19.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $88.2 million in Q1 2024 and bottomed at -$25.4 million in Q1 2025.
  • Average Net Cash Flow over 3 years is $2.6 million, with a median of -$11.7 million recorded in 2023.
  • Peak annual rise in Net Cash Flow hit 1021.77% in 2024, while the deepest fall reached 207.67% in 2024.
  • Year by year, Net Cash Flow stood at -$11.3 million in 2023, then crashed by 52.33% to -$17.2 million in 2024, then soared by 421.9% to $55.4 million in 2025.
  • Business Quant data shows Net Cash Flow for GUTS at $55.4 million in Q3 2025, -$19.8 million in Q2 2025, and -$25.4 million in Q1 2025.